Business Description
Neuren Pharmaceuticals is an Australian company focused on creating medicines for rare brain and nervous system conditions. Its approved treatment, DAYBUE, is available for Rett syndrome patients aged two and older, while several other compounds are moving through clinical trials targeting conditions such as Fragile X, Angelman, and Pitt Hopkins syndromes. Founded in 2001 and headquartered in Hawthorn East, the company continues to build a pipeline aimed at addressing serious neurological diseases that currently have few treatment options.
